Skip to content
DataLookout
Menu

EssenMAFLDNCT07194863

Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 6 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Completed without a posted recruiting period
    • Primary completion date changed from estimate of Nov 1, 2026 to Oct 1, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2026 to Oct 1, 2026
    • Study description revised
  2. Notable Start date: Nov 1, 2025 to Nov 1, 2026
    • Primary completion date: Sep 1, 2026 to Nov 1, 2026
    v3
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

evaluate the efficacy of Essential phospholipid versus Betaine HCL/L-Glutamic Acid in MAFLD
Timeframe: Baseline and at 12 weeks of treatment

Sites

1 site in 1 country

  • Assiut UniversityAsyut, Egypt